Sort
11,323 grants matching “glioblastoma”
Neuroimmunology of Malignant Brain Tumors: Innate Mechanisms
$406,525Pedro R Lowenstein · University Of Michigan At Ann Arbor · R01 · FY2016 · NS
Direct Activation of PP2A as a Novel Approach to Group-3 Medulloblastoma Therapy
$406,500Michael Ohlmeyer · Atux Iskay Group Llc · R43 · FY2022 · CA
Neural organoid models of the immunological microenvironment of glioblastoma for drug discovery applications
$406,500Connie S Lebakken · Stem Pharm, Inc. · R41 · FY2023 · CA
MT-125 for the Therapeutic Treatment of Glioblastoma
$406,500Steven S Rosenfeld · Myosin Therapeutics Inc. · R42 · FY2023 · CA
A CEST-MRI Reporter Gene for Image Guided Oncolytic Virotherapy
$406,309Christian T Farrar · Massachusetts General Hospital · R01 · FY2017 · CA
HTS for Identification of Novel Inhibitors of Pyk2 Activity
$406,260Joseph C Loftus · Mayo Clinic Arizona · R01 · FY2017 · CA
Engineering the Brain Immune System for Tumor Therapy
$406,250Maria G Castro · Cedars-Sinai Medical Center · R01 · FY2009 · NS
Characterization of extrachromosomal DNAs in tumors through computational analysis of single-cell and bulk sequencing data
$406,138Roel Gw Verhaak · Jackson Laboratory · R21 · FY2021 · CA
IDO1 and Immunotolerance in Glioblastoma
$406,136Derek Alan Wainwright · Northwestern University At Chicago · R01 · FY2020 · NS
Molecular determinants of cellular heterogeneity and therapeutic resistance in GBM.
$406,044Hernando Martin Lopez-Bertoni · Hugo W. Moser Res Inst Kennedy Krieger · R01 · FY2025 · NS
In vivo imaging of the stem cell loaded oncolytic viruses for cancer therapy
$406,031Khalid A Shah · Brigham And Women'S Hospital · R01 · FY2017 · CA
Molecular determinants of cellular heterogeneity and therapeutic resistance in GBM.
$406,026Hernando Martin Lopez-Bertoni · Hugo W. Moser Res Inst Kennedy Krieger · R01 · FY2023 · NS
Molecular determinants of cellular heterogeneity and therapeutic resistance in GBM.
$406,017Hernando Martin Lopez-Bertoni · Hugo W. Moser Res Inst Kennedy Krieger · R01 · FY2022 · NS
Project 2: Novel hyperpolarized C-13 imaging as metabolic markers of response in IDH mutant glioma
$405,940Susan M Chang · University Of California, San Francisco · P50 · FY2023 · CA
Project 3: Novel B-SYNC T cell therapy with CNS-specific expression of CAR as a safe and effective therapy for glioblastoma
$405,933Hideho Okada · University Of California, San Francisco · P50 · FY2023 · CA
Regulation and Function of Ascl1 (Mash1) in Neural Development
$405,861Jane E Johnson · Ut Southwestern Medical Center · R01 · FY2009 · NS
Project 3: Predicting therapeutic sensitivity in cancer
$405,846Anna Lasorella · Columbia University Health Sciences · U54 · FY2018 · CA
Influence of Pre-Analytical Factors in Globlastoma MGMT Promoter Methylation Biomarker Assay
$405,793Karol Bomsztyk · University Of Washington · U01 · FY2023 · CA
Intranasal Stem-Cell Based Therapy for Glioblastoma
$405,762Maciej S Lesniak · Northwestern University At Chicago · R01 · FY2017 · NS
Nanotechnology: Advancing Toxicity Testing
$405,760Kristi Lynn Haik · Northern Kentucky University · R15 · FY2011 · NS
Project 1: Sex-specific developmental epigenetics in gliomagenesis
$405,737Joshua B Rubin · Cleveland Clinic Lerner Com-Cwru · P01 · FY2022 · CA
Mouse models of glioma to study functional exRNA transfer to the microenvironmen
$405,707Xandra Owens Breakefield · Massachusetts General Hospital · U19 · FY2014 · CA
Truncated GLI1 In Glioblastoma
$405,703Hui-Wen Lo · Wake Forest University Health Sciences · R01 · FY2016 · NS
Genetics Pathways of Glioma Invasion
$405,644Michael E. Berens · Translational Genomics Research Inst · R01 · FY2008 · NS
Genetics Pathways of Glioma Invasion
$405,644Michael E. Berens · Translational Genomics Research Inst · R01 · FY2007 · NS